By Business/Source
Currency:USD
2024/FY
Stock NameRevenueRatio
Research and development of its lead product candidate, cadisegliatin1.02M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
China1M98.33%
United States17K1.67%